Cite
Lam CSP, Giczewska A, Sliwa K, et al. Clinical Outcomes and Response to Vericiguat According to Index Heart Failure Event: Insights From the VICTORIA Trial. JAMA Cardiol. 2021;6(6):706-712doi: 10.1001/jamacardio.2020.6455.
Lam, C. S. P., Giczewska, A., Sliwa, K., Edelmann, F., Refsgaard, J., Bocchi, E., Ezekowitz, J. A., Hernandez, A. F., O'Connor, C. M., Roessig, L., Patel, M. J., Pieske, B., Anstrom, K. J., Armstrong, P. W. (2021). Clinical Outcomes and Response to Vericiguat According to Index Heart Failure Event: Insights From the VICTORIA Trial. JAMA cardiology, 6(6), 706-712. https://doi.org/10.1001/jamacardio.2020.6455
Lam, Carolyn S P, et al. "Clinical Outcomes and Response to Vericiguat According to Index Heart Failure Event: Insights From the VICTORIA Trial." JAMA cardiology vol. 6,6 (2021): 706-712. doi: https://doi.org/10.1001/jamacardio.2020.6455
Lam CSP, Giczewska A, Sliwa K, Edelmann F, Refsgaard J, Bocchi E, Ezekowitz JA, Hernandez AF, O'Connor CM, Roessig L, Patel MJ, Pieske B, Anstrom KJ, Armstrong PW. Clinical Outcomes and Response to Vericiguat According to Index Heart Failure Event: Insights From the VICTORIA Trial. JAMA Cardiol. 2021 Jun 01;6(6):706-712. doi: 10.1001/jamacardio.2020.6455. PMID: 33185650; PMCID: PMC7666431.
Copy
Download .nbib